Adult stem cell transplantation: Is gender a factor in stemness?

International Journal of Molecular Sciences

Volumn 15, Issue 9, 2014, Pages 15225-15243

  Tajiri, Naoki ^a   Duncan, Kelsey ^a   Borlongan, Mia C ^a   Pabon, Mibel ^a   Acosta, Sandra ^a   De La Pena, Ike ^a   Hernadez Ontiveros, Diana ^a   Lozano, Diego ^a   Aguirre, Daniela ^a   Reyes, Stephanny ^a   Sanberg, Paul R ^a   Eve, David J ^a   Borlongan, Cesar V ^a   Kaneko, Yuji ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Autologous; Ischemic stroke; Menstrual blood; Regenerative; Sertoli cells

Indexed keywords

ADULT STEM CELL; ANIMAL; CELL DIFFERENTIATION; CYTOLOGY; FEMALE; HUMAN; MALE; PROCEDURES; SEXUAL DEVELOPMENT; STEM CELL TRANSPLANTATION; TRANSPLANTATION;

ADULT STEM CELLS; ANIMALS; CELL DIFFERENTIATION; FEMALE; HUMANS; MALE; SEX CHARACTERISTICS; STEM CELL TRANSPLANTATION;

EID: 84906822686     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms150915225     Document Type: Review

References (113)

1. Gargett, C.E.; Schwab, K.E.; Zillwood, R.M.; Nguyen, H.P.; Wu, D. Isolation and culture of epithelial progenitors and mesenchymal stem cells from human endometrium. Biol. Reprod. 2009, 80, 1136-1145.
2. Xu, J.; Kenneth, D.; Kochanek, M.A.; Sherry, L.; Murphy, B.S. Deaths, final data for 2007. Natl. Vital Stat. Rep. 2010, 58, 1-134.
3. Richard Green, A.; Odergen, T.; Ashwood, T. Animal models of stroke: Do they have value for discovering neuroprotective agents? Trends Pharmacol. Sci. 2003, 24, 402-408.
4. Chavez, J.C.; Hurko, O.; Barone, F.C.; Feuerstein, G.Z. Pharmacologic interventions for stroke: Looking beyond the thrombolysis time window into the penumbra with biomarkers, not a stopwatch. Stroke 2010, 40, e558-e563.
5. Hacke, W.; Kaste, M.; Bluhmki, E.; Brozman, M.; Davalos, A.; Guidetti, D.; Laurrue, V.; Lees, K.R.; Medeghri, Z.; Machnig, T. et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N. Engl. J. Med. 2008, 359, 1317-1329.
6. Ovbiagele, B.; Nguyen-Huynh, M.N. Stroke epidemiology: Advancing our understanding of disease mechanism and therapy. Neurotherapeutics 2011, 8, 319-329.
7. Miller, J.; Hartwell, C.; Lewandowski, C. Stroke treatment using intravenous and intra-arterial tissue plasminogen activator. Curr. Treat. Options Cardiovasc. Med. 2012, 14, 273-283.
8. Hess, D.C.; Borlongan, C.V. Cell-based therapy in ischemic stroke. Expert. Rev. Neurother. 2008, 8, 1193-1201.
9. Eissa, A.; Krass, I.; Bajorek, B.V. Optimizing the management of acute ischemic stroke: A review of the utilization of intravenous recombinant tissue plasminogen activator (tPA). J. Clin. Pharm. Ther. 2012, 37, 620-629.
10. Kriz, J. Inflammation in ischemic brain injury, timing is important. Crit. Rev. Neurobiol. 2006, 18, 145-157.
11. Amor, S.; Puentes, F.; Baker, D.; van der Valk, P. Inflammation in neurodegenerative diseases. Immunology 2010, 129, 154-169.
12. Emsley, C.A.; Smith, C.J.; Tyrrell, P.J.; Hopkins, S.J. Inflammation in acute ischemic stroke and its relevance to stroke critical care. Neurocrit. Care 2008, 9, 125-138.
13. Takano, T.; Oberbeim, N.; Cotrina, M.L.; Nedergaard, M. Astrocytes and ischemic injury. Stroke 2009, 40, S8-S12.
14. Park, D.H.; Eve, D.J.; Musso J. 3rd. Klasko, S.K.; Borlongan, C.V.; Sanberg, P.R. Inflammation and stem cell migration to the injured brain in higher organisms. Stem Cells Dev. 2009, 18, 693-701.
15. Bai, L.; Lennon, D.P.; Eaton, V.; Maier, K.; Caplan, A.I.; Miller, S.D.; Miller, R.H. Human bone marrow-derived mesenchymal stem cells induce Th2-polarized immune response and promote endogenous repair in animal models of multiple sclerosis. Glia 2009, 57, 1192-1203.
16. Boucherie, C.; Hermans, E. Adult stem cell therapies for neurological disorders: Benefits beyond neuronal replacement? J. Neurosci. Res. 2009, 87, 1509-1521.
17. Fujiwara, Y.; Tanaka, N.; Ishida, O.; Fujimoto, Y.; Murakami, T.; Kajihara, H.; Yasunaga, Y.; Ochi, M. Intravenously injected neural progenitor cells of transgenic rats can migrate to the injured spinal cord and differentiate into neurons, astrocytes and oligodendrocytes. Neurosci. Lett. 2004, 366, 287-291.
18. Hill, W.D.; Hess, D.C.; Martin-Studdard, A.; Carothers, J.J.; Zheng, J.; Hale, D.; Maeda, M.; Fagan, S.C.; Carroll, J.E.; Conway, S.J. SDF-1 (CXCL12) is upregulated in the ischemic penumbra following stroke: association with bone marrow cell homing to injury. J. Neuropathol. Exp. Neurol. 2004, 63, 84-96.
19. Daar, A.S.; Bhatt, A.; Court, E.; Singer, P.A. Stem cell research and transplantation: Science leading ethics. Transplant. Proc. 2004, 36, 2504-2506.
20. Takagi, Y.; Nishimura, M.; Morizane, A.; Takahashi, J.; Nozaki, K.; Hayashi, J.; Hashimoto, N. Survival and differentiation of neural progenitor cells derived from embryonic cells and transplanted into ischemic brain. J. Neurosurg. 2004, 103, 304-310.
21. Ikegame, Y.; Yamashita, K.; Hayashi, S.; Mizuno, H.; Tawada, M.; You, F.; Yamada, K.; Tanaka, Y.; Egashira, Y.; Nakashima, S. et al. Comparison of mesenchymal stem cells from adipose tissue and bone marrow for ischemic stroke therapy. Cytotherapy 2011, 13, 675-685.
22. Patel, A.N.; Park, E.; Kuzman, M.; Benetti, F.; Silva, F.J.; Allickson, J.G. Multipotent menstrual blood stromal stem cells: Isolation, characterization and differentiation. Cell Transplant. 2008, 17, 303-311.
23. Hida, N.; Nishiyama, N.; Miyoshi, S.; Kira, S.; Segawa, K.; Uyama, T.; Mori, T.; Miyado, K.; Ikegami, Y.; Cui, C. et al. Novel cardiac precursor-like cells from human menstrual blood-derived mesenchymal cells. Stem Cells 2008, 26, 1695-1704.
24. Borlongan, C.V.; Kaneko, Y.; Maki, M.; Yu, S.J.; Ali, M.; Allickson, J.G.; Sanberg, C.D.; Kuzmin-Nichols, N.; Sanberg, P.R. Menstrual blood cells display stem cell-like phenotypic markers and exert neuroprotection following transplantation in experimental stroke. Stem Cells 2010, 19, 439-451.
25. Murphy, M.P.; Wang, H.; Patel, A.N.; Kambhampati, S.; Angle, N.; Chan, K.; Marleau, A.M.; Pysznika, A.; Carrier, E.; Ichim, T.E. et al. Allogeneic endometrial regenerative cells, an "off the shelf solution" for critical limb ischemia? J. Transl. Med. 2008, 6, 45.
26. Wolff, E.F.; Gao, X.B.; Andrews, Z.B.; Du, H.; Elsworth, J.D.; Taylor, H.S. Endometrial stem cell transplantation restores dopamine production in a Parkinson's disease model. J. Cell. Mol. Med. 2011, 15, 747-755.
27. Borlongan, C.V.; Cameron, D.F.; Saporta, S.; Sandberg, P.R. Intracerebral transplantation of testis-derived SC promotes functional recovery in female rats with 6-hydroxydopamine-induced hemiparkinsonism. Exp. Neurol. 1997, 148, 388-392.
28. Saporta, S.; Cameron, D.F.; Borlongan, C.V.; Sanberg, P.R. Survival of rat and porcine Sertoli cell transplants in the rat striatum without cyclosporine-A immunosuppression. Exp. Neurol. 1997, 146, 299-304.
29. Yamori, Y.; Nagaoka, A.; Okamoto, K. Importance of genetic factors in stroke: An evidence obtained by selective breeding of stroke-prone and stroke-resistant SHR. Circ. J. 1974, 38, 1095-1100.
30. Sudlow, C.L.; Warlow, C.P. Comparable studies of the incidence of stroke and its pathological types: Results from an international collaboration. Stroke 1997, 28, 491-499.
31. Bairey Merz, C.N.; Mark, S.; Boyan, B.D.; Jacobs, A.K.; Shah, P.K.; Taylor, D.; Marban, E. Proceedings from the scientific symposium: Sex differences in cardiovascular disease and implications for therapies. J. Womens Health 2010, 19, 1059-1072.
32. Vitale, C.; Fini, M.; Speziale, G.; Chierchia, S. Gender differences in the cardiovascular effects of sex hormones. Fundam. Clin. Pharmacol. 2010, 24, 675-685.
33. Chiang, N.; Hurwitz, S.; Ridker, P.M.; Serhan, C.N. Aspirin has a gender-dependent impact on antiinflammatory 15-epi-lipoxin A4 formation: a randomized human trial. Arterioscler. Thromb. Vasc. Biol. 2006, 26, e14-e17.
34. Chiang, N.; Serhan, C.N. New mechanism for an old drug: Aspirin triggers anti-inflammatory lipid mediators with gender implications. Compr. Ther. 2006, 32, 150-157.
35. Kumar, A.; Vishvakarma, N.K.; Bharti, A.C.; Singh, S.M. Gender-specific antitumor action of aspirin in a murine model of a T-cell lymphoma bearing host. Blood Cells Mol. Dis. 2012, 48, 137-144.
36. Duckles, S.P.; Krause, D.N. Mechanisms of cerebrovascular protection: Oestrogen, inflammation, and mitochondria. Acta Physiol. 2011, 203, 149-154.
37. Skaletsky, H.; Kuroda-Kawaguchi, T.; Minx, P.J.; Cordum, H.S.; Hillier, L.; Brown, L.G.; Repping, S.; Pyntikova, T.; Ali, J.; Bieri, T. et al. The male-specific region of the human Y chromosome is a mosaic of discrete sequence classes. Nature 2003, 423, 825-837.
38. Bund, D.; Buhmann, R.; Gökmen, F.; Zorn, J.; Kolb, H.J.; Schmetzer, H.M. Minor histocompatibility antigen UTY as target for gGaft-versus-leukemia and graft-versus-haematopoiesis in the canine model. Scand. J. Immunol. 2013, 77, 39-53.
39. Herson, P.S.; Hurn, P.D. Gender and the injured brain. Prog. Brain Res. 2010, 186, 177-187.
40. Lang, J.T.; McCullough, L.D. Pathways to ischemic neuronal cell death: Are sex differences relevant? J. Transl. Med. 2008, 6, 33.
41. McCullough, L.D.; Zeng, Z.; Blizzard, K.K.; Debchoudhury, I.; Hurn, P.D. Ischemic nitric oxide and poly (ADP-ribose) polymerase-1 in cerebral ischemia: Male toxicity, female protection. J. Cereb. Blood Flow Metab. 2005, 25, 502-512.
42. Yuan, M.; Siegel, C.; Zeng, Z.; Li, J.; Liu, F.; McCullough, L.D. Sex differences in the response to activation of the poly (ADP-ribose) polymerase pathway after experimental stroke. Exp. Neurol. 2009, 217, 210-218.
43. Renolleau, S.; Fau, S.; Goyenvalle, C.; Joly, L.M.; Chavier, D.; Jacotot, E.; Mariani, J.; Charriaut-Marlangue, C. Specific caspase inhibitor Q-VD-OPh prevents neonatal stroke in P7 rat: A role for gender. J. Neurochem. 2007, 100, 1062-1071.
44. Liu, M.; Hurn, P.D.; Roselli, C.E.; Alkayed, N.J. Role of P450 aromatase in sex-specific astrocytic cell death. J. Cereb. Blood Flow Metab. 2007, 27, 135-141.
45. Ajmo, C.T., Jr.; Vernon, D.O.; Collier, L.; Hall, A.A.; Garbuzova-Davis, S.; Willing, A.; Pennypacker, K.R. The Spleen Contributes to Stroke-Induced Neurodegeneration. J. Neurosci. Res. 2008, 86, 2227-2234.
46. Dirnagl, U.; Klehmet, J.; Braun, J.S.; Harms, H.; Meisel, C.; Ziemssen, T.; Prass, K.; Meisel, A. Stroke-induced immunodepression: Experimental evidence and clinical relevance. Stroke 2007, 38, 770-773.
47. Offner, H.; Vandenbark, A.A.; Hurn, P.D. Effect of experimental stroke on peripheral immunity: CNS ischemia induces profound immunosuppression. Neuroscience 2009, 158, 1098-1111.
48. Zhang, B.; Subramanian, S.; Dziennis, S.; Jia, J.; Uchida, M.; Akiyoshi, K.; Migliati, E.; Lewis, A.D.; Vandenbrak, A.A.; Offner, H. et al. Estradiol and G1 reduce infarct size and improve immunosuppression after experimental stroke. J. Immunol. 2010, 184, 4087-4094.
49. Chiappetta, O.; Gliozzi, M.; Siviglia, E.; Amantea, D.; Morrone, L.A.; Berliocchi, L.; Bagetta, G.; Corasaniti, M.T. Evidence to implicate early modulation of interleukin-1β expression in the neuroprotection afforded by 17β-estradiol in male rats undergone transient middle cerebral artery occlusion. Int. Rev. Neurobiol. 2007, 82, 357-372.
50. Li, J.; Siegel, M.; Yuan, M.; Zeng, Z.; Finnucan, L.; Persky, R.; Hurn, P.D.; McCullough, L.D. Estrogen enhances neurogenesis and behavioral recovery after stroke. J. Cereb. Blood Flow Metab. 2011, 31, 413-425.
51. Selvamani, A.; Sohrabji, F. The neurotoxic effects of estrogen on ischemic stroke in older female rats is associated with age-dependent loss of insulin-like growth factor-1. J. Neurosci. 2010, 30, 6852-6861.
52. Yuan, J.; Yu, J-X.; Ge, J. Sexual dimorphism on the neurogenic potential of rhesus monkeys mesenchymal stem cells. Biochem. Biophys. Res. Comm. 2010, 396, 394-400.
53. Waldron, J.; McCourty, A.; Lecanu, L. Aging differentially affects male and female neural stem cell neurogenic properties. Stem Cells Cloning 2010, 3, 119-127.
54. Nakada, D.; Oquro, H.; Levi, B.P.; Ryan, N.; Kitano, A.; Saitoh, Y.; Takeichi, M.; Wendt, G.R.; Morrison, S.J. Oestrogen increases haematopoietic stem-cell self-renewal in females during pregnancy. Nature 2014, 505, 555-558.
55. Stern, M.; Brand, R.; de Witte T.; Sureda, A.; Rocha, V.; Passweg, J.; Baldomero, H.; Niederwiesse, D.; Gratwohl, A. Female-versus-male alloreactivity as a model for minor histocompatibility antigens in hematopoietic stem cell transplantation. Am. J. Transplant. 2008, 8, 2149-2157.
56. Crisostomo, P.R.; Wang, M.; Herring, C.M.; Markel, T.A.; Meldrum, K.K.; Lillemoe, K.D.; Meldrum, D.R. Gender differences in injury induced mesenchymal stem cell apoptosis and VEGF, TNF, IL-6 expression: Role of the 55 kDa TNF receptor (TNFR1). J. Mol. Cell Cardiol. 2007, 42, 142-149.
57. Crisostomo, P.R.; Markel, T.A.; Wang, M.; Lahm, T.; Lillemoe, K.D.; Meldrum, D.R. In the adult mesenchymal stem cell population, source gender is a biologically relevant aspect of protective power. Surgery 2007, 142, 215-221.
58. Zenovich, A.G.; Panoskaltsis-Mortari, A.; Caron, G.J.; Kolb, A.G.; Fremming, R.; Nelson, W.D.; Taylor, D.A. Sex-based differences in vascular repair with bone marrow cell therapy: Relevance of regulatory and Th2-type cytokines. Transplant. Proc. 2008, 40, 641-643.
59. Nelson, W.D.; Zenovich, A.G.; Ott, H.C.; Stolen, C.; Caron, G.J.; Panoskaltsis-Mortari, A.; Barnes S.A. 3rd.; Xin, X.; Taylor, D.A. Sex-dependent attenuation of plaque growth after treatment with bone marrow mononuclear cells. Circ. Res. 2007, 101, 1319-1327.
60. Waldron, J.; McCourty, A.; Lecanu, L. Neural stem cell sex dimorphism in aromatase (CYP19) expression: A basis for differential neural fate. Stem Cells Cloning 2010, 3, 175-182.
61. Cavaco, J.E.; Laurentino, S.S.; Barros, A.; Sousa, M.; Socorro, S. Estrogen receptors α and β in human testis: Both isoforms are expressed. Syst. Biol. Reprod. Med. 2009, 55, 137-144.
62. Berensztein, E.B.; Baquedano, M.S.; Gonzalez, C.R.; Saraco, N.I.; Rodriguez, J.; Ponzio, R.; Rivarola, M.A.; Belgorosky, A. Expression of aromatase, estrogen receptor α and β, androgen receptor, and cytochrome P-450scc in the human early prepubertal testis. Pediatr. Res. 2006, 60, 740-744.
63. Bonagura, T.W.; Zhou, H.; Babischkin, J.S.; Pepe, G.J.; Albrecht, E.D. Expression of P-450 aromatase, estrogen receptor α and β, and α-inhibin in the fetal baboon testis after estrogen suppression during the second half of gestation. Endocrine 2011, 39, 75-82.
64. Critchley, H.O.; Brenner, R.M.; Henderson, T.A.; Williams, K.; Nayak, N.R.; Slayden, O.D.; Millar, M.R.; Saunders, P.T.K. Estrogen receptor β, but not estrogen receptor α, is present in the vascular endothelium of the human and nonhuman primate endometrium. J. Clin. Endocrinol. Metab. 2001, 86, 1370-1378.
65. Shreihofer, D.A.; Ma, Y. Estrogen receptors and ischemic neuroprotection: Who, what, where, and when? Brain Res. 2013, 1514, 107-122.
66. Waldron, J.; Lecanu, L. Age and sex differences in neural stem cell transplantation: A descriptive study rats. Stem Cells Cloning 2011, 24, 25-37.
67. Lecanu, L. Sex, the underestimated potential determining factor in brain tissue repair strategy. Stem Cells Dev. 2011, 20, 2031-2035.
68. Shamekh, R.; el-Badri, N.S.; Saporta, S.; Pascual, C.; Sanberg, P.R.; Cameron, D.F. Sertoli cells induce systemic donor-specific tolerance in xenogenic transplantation model. Cell Transplant. 2006, 15, 45-53.
69. Golat, B.T.; Cameron, D.F. Sertoli cells enhance formation of capillary-like structures in vitro. Cell Transplant. 2008, 17, 1135-1144.
70. Prianishnikov, V.A. On the concept of stem cell and a model of functional-morphological structure of the endometrium. Contraception 1978, 18, 213-223.
71. Meng, X.; Ichim, T.E.; Zhong, J.; Rogers, A.; Yin, Z.; Jackson, J.; Wang, H.; Ge, W.; Bogin, V.; Chan, K.W. et al. Endometrial regenerative cells: A novel stem cell population. J. Transl. Med. 2007, 5, 57.
72. Allickson, J.G.; Sanchez, A.; Yeflmenko, N.; Borlongan, C.V.; Sanberg, P.R. Recent studies assessing the proliferative capability of a novel adult stem cell identified in menstrual blood. Open Stem Cell J. 2011, 3, 4-10.
73. Cui, C.H.; Uyama, T.; Miyado, K.; Terai, M.; Kyo, S.; Kiyono, T.; Umezawa, A. Menstrual blood-derived cells confer human dystrophin expression in the murine model of duchenne muscular dystrophy via cell fusion and myogenic transdifferentiation. Mol. Biol. Cell. 2007, 18, 1586-1594.
74. Chan, R.W.; Schwab, K.E.; Gargett, C.E. Clonogenicity of human endometrial epithelial and stromal cells. Biol. Reprod. 2004, 70, 1738-1750.
75. Rodrigues, C.D.; Asensi, K.D.; Vairo, L.; Azevedo-Pereira, R.L.; Silva, R.; Rondinelli, E.; Goldenberg, R.C.; Campos de Carvalho, A.C.; Urmenyi, T.P. Human menstrual blood-derived mesenchymal cells as a cell source of rapid and efficient nuclear reprogramming. Cell Transplant. 2012, 21, 2215-2224.
76. Oliveira Rodrigues, M.C.; Voltarelli, J.; Sanberg, P.R.; Allickson, J.G.; Kuzmin-Nichols, N.; Garbuzova-Davis, S.; Borlongan, C. Recent progress in cell therapy for basal ganglia disorders with emphasis on menstrual cell transplantation in stroke. Neurosci. Biobehav. Rev. 2012, 36, 177-190.
77. Ketema, M.; Kraft, M.; Secades, P.; Janssen, H.; Sonnenberg, A. Nesprin-3 connects plectin and vimentin to the nuclear envelope of Sertoli cells but is not required for Sertoli cell function in spermatogenesis. Am. Soc. Cell Biol. 2013, 24, 2454-2466.
78. Wan, H.T.; Mruk, D.D.; Wong, C.K.; Cheng, C.Y. Perfluoroooctanesulfonate (PFOS) perturbs male rate Sertoli cell blood-testis barrier function by affecting F-actin organization via p-FAK-Tyr (407): An in vitro study. Endocrinology 2014, 155, 249-262.
79. Emerich, D.F.; Hemendinger, R.; Halberstadt, C.R. The testicular-derived Sertoli cell: Cellular immunoscience to enable transplantation. Cell Transplant. 2003, 12, 335-349.
80. Rodriguez, A.I.; Willing, A.E.; Saporta, S.; Cameron, D.F.; Sanburg, P.R. Effects of Sertoli cell transplants in a 3-nitropropionic acid model of early Huntington's disease: A preliminary study. Neurotox. Res. 2003, 5, 443-450.
81. Selawry, H.P.; Cameron, D.F. Sertoli cell-enriched fractions in successful islet cell transplantation. Cell Transplant. 1993, 2, 123-129.
82. Shamekh, R.; Newcomb, J.; Mallery, J.; Cassady, C.J.; Saporta, S.; Cameron, D.F. Survival of rat or mouse ventral mesencephalon neurons after o-transplantation with rat Sertoli cells in the mouse striatum. Cell Transplant. 2005, 14, 551-564.
83. Skinner, M. Sertoli cell secreated regulatory factors, In Sertoli Cell Biology; Skinner, M., Griswold, M., Eds.; Elsevier Academic Press: San Diego, CA, USA, 2005; pp. 95-120.
84. Skinner, M.K. General Considerations. In The Sertoli Cell Cache River Press; Russell, L.D., Griswold, M.D., Eds.; River Press: Clearwater, FL, USA, 2003; pp. 237-247.
85. Li, Y.; Xu, W.; Liu, H.; Fan, P.; Wang, X.; Ding, X.; Tian, X.; Feng, X.; Pan, X.; Zheng, J. et al. Combined strategy of endothelial cells coating, Sertoli cells coculture and infusion improves vascularization and rejection protection of islet graft. PLoS One 2013, 8, e56696.
86. Bellgrau, D.; Gold, D.; Selawry, H.; Moore, J.; Franzusoff, A.; Duke, R.C. A role for CD-95 ligand in preventing graft rejection. Nature 1995, 377, 630-632.
87. Sanberg, P.R.; Saporta, S.; Borlongan, C.V.; Othberg, A.L.; Allen, R.C.; Cameron, D.F. The testis-derived cultured Sertoli cell as a natural fas-L secreting cell for immunosuppressive cellular therapy. Cell Transplant. 1997, 62, 191-193.
88. Davidoff, M.S.; Middendorff, R.; Koeva, Y.; Pusch, W.; Jezek, D.; Muller, D. Glial cell line-derived neurotrophic factor (GDNF) and its receptors GFRα-1 and GFRα-2 in the human testis. Ital. J. Anat. Embryol. 2001, 106, 173-180.
89. Hofmann, M.C. GDNF signaling pathways within the mammalian spermatogonial stem cell niche. Mol. Cell. Endocrinol. 2008, 288, 95-103.
90. Dufour, J.M.; Rajotte, R.V.; Korbutt, G.S.; Emerich, D.F. Harnessing the immunomodulatory properties of Sertoli cells to enable xenotransplantation in type I diabetes. Immunol. Investig. 2003, 32, 275-297.
91. Buganim, Y.; Itskovich, E.; Hu, Y.; Cheng, A.W.; Ganz, K.; Sarkar, S.; Fu, D.; Welstead, G.G.; Page, D.C.; Jaenissch, R. Direct reprogramming of fibroblasts into embryonic Sertoli-like cells by defined factors. Cell Stem Cell 2012, 3, 373-386.
92. Zhong, Z.; Patel, A.N.; Ichim, T.E.; Ichim, T.E.; Riordan, N.H.; Wang, H.; Min, W.; Woods, E.J.; Reid, M.; Mansilla, R. et al. Feasibility investigation of allogeneic endometrial regenerative cells. J. Transl. Med. 2009, 7, 15.
93. Fan, X.; Krieg, S.; Kuo, C.J.; Wiegand, S.J.; Rabinovitch, M.; Druzin, M.L; Brenner, R.M.; Giudice, L.C.; Nayak, N.R. VEGF blockade inhibits angiogenesis and reepithelialization of endometrium. FASEB J. 2008, 22, 3571-3580.
94. Drago, H.; Marín, G.H.; Sturla, F.; Roque, G.; Mártire, K.; Díaz Aquino, V.; Lamonega, R.; Gardiner, C.; Ichim, T.; Riordan, N. et al. The next generation of burns treatment, intelligent films and matrix, controlled enzymatic debridement, and adult stem cells. Transplant. Proc. 2010, 42, 345-349.
95. Sanberg, P.R.; Borlongan, C.V.; Saporta, S.; Cameron, D.F. Sertoli cells: An alternative cell source for neural transplantation in Parkinson's disease. Exp. Neurol. 1995, 135, 169.
96. Sanberg, P.R.; Borlongan, C.V.; Saporta, S.; Cameron, D.F. Testis-derived Sertoli cells survive and provide localized immunoprotection for xenografts in rat brain. Nat. Biotechnol. 1996, 14, 1692-1695.
97. Sanberg, P.R.; Othberg, A.I.; Borlongan, C.V.; Saporta, S.; Anton, A.; Freeman, T.B.; Cahill, D.W.; Allen, R.C.; Cameron, D.F. Transplantation of testis-derived Sertoli cells into the mammalian brain. Transplant. Proc. 1997, 29, 1926-1928.
98. Abo-Elmaksoud, A.; Sinowatz, F. Expression and localization of growth factors and their receptors in the mammalian testis. Part I: Fibroblast growth factors and insulin-like growth factors. Anat. Histol. Embryol. 2005, 34, 319-334.
99. Reddy, N.; Kasukurthi, K.B.; Mahla, R.S.; Pawar, R.M.; Goel, S. Expression of vascular endothelial growth factor (VEGF) transcript and protein in the testis of several vertebrates including endangered species. Theriogenology 2012, 77, 608-614.
100. Ferreira, L.M.; Mostajo-Radji, M.A. How induced pluripotent stem cells are redefining personalized medicine. Gene 2013, 520, 1-6.
101. Zhang, M.J.; Liu, B.; Xia, W.; Sun, Z.Y.; Lu, K.H. Could cells from menstrual blood be a new source for cell-based therapies? Med. Hypotheses 2009, 72, 252-254.
102. Itman, C.; Wong, C.; Hunyadi, B.; Ernst, M.; Jans, D.A.; Loveland, K.L. Smad3 dosage determines androgen responsiveness and sets the pace of postnatal testis development. Endocrinology 2011, 152, 2076-2089.
103. Tarulli, G.A.; Stanton, P.G.; Meachem, S.J. Is the adult Sertoli cell terminally differentiated? Biol. Reprod. 2012, 87, 1-11.
104. Halley, K.; Dyson, E.L.; Kaur, G; Mital, P.; Uong, P.M.; Dass, B.; Crowell, S.N.; Dufours, J.M. Delivery of a therapeutic protein by immune-privileged Sertoli cells. Cell Transplant. 2010, 19, 1645-1657.
105. Nurmio, M.; Keros, V.; Lähteenmäki, P.; Salmi, T.; Kallajoki, M.; Jahnukainen, K. Effect of childhood acute lymphoblastic leukemia therapy on spermatogonia populations and future fertility. J. Clin. Endocrinol. Metab. 2009, 94, 2119-2122.
106. Izadyar, F.; Spierenberg, G.T.; Creemers, L.B.; den Ouden, K.; de Rooij, D.G. Isolation and purification of type A spermatogonia from the bovine testis. Reproduction 2002, 124, 85-94.
107. Ryser, S.; Glauser, D.; Vigier, M.; Zhang, Y.Q.; Tachini, P.; Schlegel, W.; Durand, P.; Irminger-Finger, I. Gene expression profiling of rat spermatogonial and sertoli cells reveals signaling pathways from stem cells to niche and testicular cancer cells to surrounding stroma. BMC Genomics 2011, 12, 29.
108. Brinster, C.J.; Ryu, B.Y.; Avarbock, M.R.; Karagenc, L.; Brinster, R.L.; Orwig, K.E. Restoration of fertility by germ cell transplantation requires effective recipient preparation. Biol. Reprod. 2003, 69, 412-420.
109. Shinohara, T.; Orwig, K.E.; Avarbock, M.R.; Brinster, R.L. Remodeling of the postnatal mouse testis is accompanied by dramatic changes in stem cell number and niche accessibility. Proc. Nat. Acad. Sci. USA 2001, 98, 6186-6191.
110. McLean, D.J.; Friel, P.J.; Johnston, D.S.; Griswold, M.D. Characterization of spermatogonial stem cell maturation and differentiation in neonatal mice. Biol. Reprod. 2003, 69, 2085-2091.
111. Yoshida, S.; Sukeno, M.; Nakagawa, T.; Ohbo, K.; Nagamatsu, G.; Suda, T.; Nabeshima, Y. The first round of mouse spermatogenesis is a distinctive program that lacks the self-renewing spermatogonia stage. Development 2006, 133, 1495-1505.
112. Nakagawa, T.; Nabeshima, Y.; Yoshida, S. Functional identification of the actual and potential stem cell compartments in mouse spermatogenesis. Dev. Cell 2007, 12, 195-206.
113. Drummond, A.E.; Britt, K.L.; Dyson, M.; Jones, M.E.; Kerr, J.B.; O'Donnell, L.; Simpson, E.R.; Findlay, J.K. Ovarian steroid receptors and their role in ovarian function. Mol. Cell. Endocrinol. 2002, 191, 27-33.